Opendata, web and dolomites

CaReSyAn SIGNED

Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CaReSyAn project word cloud

Explore the words cloud of the CaReSyAn project. It provides you a very rough idea of what is the project "CaReSyAn" about.

extremely    diseases    scientific    technologies    excellent    mechanistic    entrepreneurs    patients    combatting    basic    scientists    personal    cardiorenal    broadly    45    caresyan    services    business    ckd    bioinformatics    close    kidneys    therapy    crs    patient    heart    training    molecular    century    vessels    cornerstone    extend    kidney    pathology    caused    sme    cvd    integrating    academic    builds    treatment    disorders    chronic    industry    animals    cooperation    strives    syndrome    translation    disease    exactly    environments    burden    cohorts    ongoing    insights    diagnosis    functional    vitro    complementary    methodically    cardiovascular    experimental    deaths    nurture    skills    solely    killer    young    career    programs    socio    synergistically    academia    integrate    bridges    cooperations    generate    technological    bridge    disciplinary    innovative    successfully    proteomics    structural    bioinformatical    train    economic    clinical    exposure    trained   

Project "CaReSyAn" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAETSKLINIKUM AACHEN 

Organization address
address: Pauwelsstrasse 30
city: AACHEN
postcode: 52074
website: www.ukaachen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙795˙346 €
 EC max contribution 2˙795˙346 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAETSKLINIKUM AACHEN DE (AACHEN) coordinator 747˙649.00
2    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 263˙659.00
3    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 262˙875.00
4    RD NEPHROLOGIE SAS FR (MONTPELLIER) participant 262˙875.00
5    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) participant 255˙934.00
6    DSM MATERIALS SCIENCE CENTER BV NL (GELEEN) participant 255˙374.00
7    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 255˙374.00
8    MOSAIQUES DIAGNOSTICS GMBH DE (HANNOVER) participant 249˙216.00
9    IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON EL (ATHINA) participant 242˙386.00
10    DSM R & D SOLUTIONS BV NL (SITTARD) participant 0.00
11    "EUTox, working group of the ""European Society of Artificial Organs"" (ESAO)" AT (Krems) partner 0.00
12    Bayer Pharma AG DE (Berlin) partner 0.00
13    Fresenius Medical Care Deutschland GmbH DE (BAD HOMBURG) partner 0.00
14    INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ ES (MADRID) partner 0.00
15    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) partner 0.00

Map

 Project objective

Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accomplish exactly this: we will train scientists to successfully integrate proteomics, clinical, experimental and bioinformatical analyses to enhance the understanding, diagnosis and therapy of the cardiorenal syndrome (CRS). CRS comprises disorders of the heart, vessels and kidneys, including the increased development of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). With ~45% of all deaths in CKD patients caused by CVD, the socio-economic burden of CRS is extremely high.

CaReSyAn will train scientists in a close cooperation between academia, SME and industry partners. Key objectives are to provide: 1) Excellent scientific training on CRS pathology, integrating clinical/mechanistic knowledge with technological skills (animals and in vitro, molecular and functional studies, proteomics and bioinformatics) to generate innovative insights triggering the understanding, diagnosis and treatment of the CRS; 2) Excellent complementary skills in personal and career development as well as business training required to extend beyond scientific research; and 3) Exposure to both academic and non-academic environments, required to build bridges between researchers and entrepreneurs and support the future translation of research findings in innovative products and services. CaReSyAn builds on already available patient cohorts, advanced technologies and established cooperations. CaReSyAn is complementary to ongoing European programs focusing solely on CKD or CVD and strives to synergistically improve structural training on European level. CaReSyAn will nurture the development of young, broadly-trained scientists able to successfully bridge clinical with basic research as well as academia and industry. This is a cornerstone in effectively combatting complex diseases as CRS, a major killer of this century.

 Publications

year authors and title journal last update
List of publications.
2019 Eleni Petra, Jerome Zoidakis, Antonia Vlahou
Protein biomarkers for cardiorenal syndrome
published pages: 325-336, ISSN: 1478-9450, DOI: 10.1080/14789450.2019.1592682
Expert Review of Proteomics 16/4 2020-04-09
2019 Tianlin He
Implementation of Proteomics in Clinical Trials
published pages: 1800198, ISSN: 1862-8346, DOI: 10.1002/prca.201800198
PROTEOMICS – Clinical Applications 13/2 2020-04-09
2019 Sam Hobson, Samsul Arefin, Karolina Kublickiene, Paul Shiels, Peter Stenvinkel
Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease—A Novel Target for Treatment
published pages: 82, ISSN: 2072-6651, DOI: 10.3390/toxins11020082
Toxins 11/2 2020-04-09
2019 Julie Klein, Joost P Schanstra
Implementation of Proteomics Biomarkers in Nephrology: From Animal Models to Human Application?
published pages: 1800089, ISSN: 1862-8346, DOI: 10.1002/prca.201800089
PROTEOMICS – Clinical Applications 13/2 2020-04-09

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARESYAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARESYAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More  

Shape-IT (2019)

Supporting the interaction of Humans and Automated vehicles: Preparing for the EnvIronment of Tomorrow

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More